NCT02270853UnknownNot Applicable
Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- RWTH Aachen University
- Enrollment
- 100
- Locations
- 6
- Primary Endpoint
- percent of sleep apnea in patients with bronchial carcinoma
Study Overview
Brief Summary
In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
Detailed Description
Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard screening tool for sleep apnea in clinical practice.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Screening
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with reasonable suspicion of bronchial carcinoma or histologically proven bronchial carcinoma, which has not been medicated until the study entry and
- •Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.
Exclusion Criteria
- •Pregnancy
- •other already known malignancies or tumors
- •Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies
Outcomes
Primary Outcomes
percent of sleep apnea in patients with bronchial carcinoma
Time Frame: two days
The percent of sleep apnea in a cohort of patients with bronchial carcinoma will be evaluated. The duration of the study participation is two days.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (6)
Loading locations...
Similar Trials
Completed
Not Applicable
Prevalence of Sleep Apnea in Patients Presenting for Hip or Knee Replacement SurgerySleep Apnea, ObstructiveNCT00874822University of Nebraska216
Recruiting
Not Applicable
Investigation on effects of sleep apnea syndrome (SAS) and its CPAP treatment on serum KL-6 level.Sleep apnea syndromeJPRN-UMIN000032953Kurume University school of medicine,Depertment of Neuropsychiatry100
Recruiting
Not Applicable
Prevalence and Impact of Obstructive Sleep Apnea in Multiple SclerosisObstructive Sleep ApneaMultiple SclerosisNCT04603196Beth Israel Deaconess Medical Center800
Terminated
Not Applicable
Epidemiology of Sleep Apnea SyndromeLung DiseasesSleep Apnea SyndromesNCT00005286University of New Mexico
Completed
Not Applicable
OSA and Sudden Sensorineural Hearing LossObstructive Sleep ApneaSudden Hearing LossNCT03747874Poitiers University Hospital10